Skip to main content

Table 1 Characteristics and chronic comorbidities of MASLD and MASH individuals

From: Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort

N = 14,437

 

Male sex n (%)

9911 (68.6)

Mean age in 2018 (SD)

53 (12)

Social Deprivation index, n (%)

 

1st quartile (least deprived)

1879 (13)

2nd quartile

2481 (17.2)

3rd quartile

2838 (19.7)

4th quartile

3354 (23.2)

5th quartile (most deprived)

3885 (26.9)

Educational level, n (%)

 

No diploma

621 (4.3)

College, Certificate of primary or secondary education, GCE or A level

4690 (32.5)

high school

2495 (17.3)

higher education

6416 (44.4)

Other

215 (1.5)

Charlson Comorbidity Index

0.8 (1.3)

BMI at inclusion, Mean (SD)

31.5 (4.4)

> 30 n (%)

8377 (58.0)

Waist circumference at inclusion, Mean (SD)

103.9 (9.5)

Comorbidities in 2018, n (%)

 

Cardio metabolic disease: hypertension, hyperlipidemia, diabetes

4765 (33.0)

mental health disorders

1839 (12.7)

Cardiovascular diseases and stroke

1036 (7.2)

Respiratory disease

854 (5.9)

Cancer

307 (2.1)

HIV infection or AIDS

31 (0.2)

Chronic inflammatory disease

261 (1.8)

Neurodegenerative disease

141 (1.0)

  1. SD standard deviation